Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 16, Issue 9, Pages 1220-1228
Publisher
Oxford University Press (OUP)
Online
2014-03-28
DOI
10.1093/neuonc/nou034
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging insights into the molecular and cellular basis of glioblastoma
- (2012) G. P. Dunn et al. GENES & DEVELOPMENT
- Survivin Signaling in Clinical Oncology: A Multifaceted Dragon
- (2012) Jagat R. Kanwar et al. MEDICINAL RESEARCH REVIEWS
- Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma
- (2012) Tiffany A. Doucette et al. NEURO-ONCOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Vaccines for glioblastoma and high-grade glioma
- (2011) Christopher J Wheeler et al. Expert Review of Vaccines
- The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma
- (2011) K. P. L. Bhat et al. GENES & DEVELOPMENT
- Genetic modeling of gliomas in mice: New tools to tackle old problems
- (2011) Dolores Hambardzumyan et al. GLIA
- Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma
- (2011) Y. Huang et al. JOURNAL OF CLINICAL PATHOLOGY
- Survivin promotes glioma angiogenesis through vascular endothelial growth factor and basic fibroblast growth factor in vitro and in vivo
- (2011) Peng Wang et al. MOLECULAR CARCINOGENESIS
- RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo
- (2011) S. Hendruschk et al. NEURO-ONCOLOGY
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Antitumor cytotoxic T-cell response induced by a survivin peptide mimic
- (2010) Michael J. Ciesielski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma
- (2010) Tiffany Doucette et al. INTERNATIONAL JOURNAL OF CANCER
- Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo
- (2010) J. George et al. NEURO-ONCOLOGY
- Differential expression of survivin and its splice variants, survivin-ΔEx3 and survivin-2B, in bladder cancer
- (2009) Yaser Atlasi et al. Cancer Detection and Prevention
- The hemopexin domain of MMP-9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice
- (2008) Ravesanker Ezhilarasan et al. INTERNATIONAL JOURNAL OF CANCER
- Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma
- (2008) Salvatore De Maria et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy
- (2008) Jian Gang Zhang et al. JOURNAL OF NEURO-ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started